SCHEMBL5959115

SCHEMBL5959115

Cc1cc(C)c(-n2cc[n+](-c3c(C)cc(C)cc3C)c2)c(C)c1.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.39

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 3/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.37
▸ LMNA P02545 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ TERT O14746 1/20 0.32
▸ CA12 O43570 1/20 0.30
▸ CA3 P07451 1/20 0.30
▸ CA6 P23280 1/20 0.30
▸ CA5A P35218 1/20 0.30
▸ CA7 P43166 1/20 0.30
▸ CA9 Q16790 1/20 0.30
▸ CA5B Q9Y2D0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL325542 0.88 ALDH1A1 (0.31) RAPGEF4MAPTHTT
SCHEMBL818966 0.83 — —
Trifluoromethanesulfonic Acid SCHEMBL6483813 0.83 GPR3 (0.32) —
Iodide SCHEMBL670623 0.81 — —
Hydrochloric Acid SCHEMBL534853 0.81 — —
Hydrochloric Acid SCHEMBL1156276 0.81 — —
Hydrochloric Acid SCHEMBL5385230 0.80 — —
Hydrochloric Acid SCHEMBL30102493 0.80 — —
Bicarbonate SCHEMBL29742345 0.79 KDM4E (0.30) KDM4E
SCHEMBL2827554 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026523-B2 Method for telomerizing non-cyclic olefins OXENO OLEFINCHEMIE GMBH (DE) 2006-04-11 — — US disclosed
US-20050038273-A1 Method for telomerizing non-cyclic olefins OXENO OLEFINCHEMIE GMBH (DE) 2005-02-17 — — US disclosed
EP-1406852-B1 METHOD FOR TELOMERIZING NON-CYCLIC OLEFINS OXENO OLEFINCHEMIE GMBH (DE) 2004-11-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038273-A1 Method for telomerizing non-cyclic olefins PCNA, TELO2, TTI1 RAPGEF4 2139/4885FFAR4 4395/4885LMNA 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback